Skinvisible, Inc. (SKVI): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$66.0K
As of 2021-12-31
+198.5%
3-year compound annual growth
2018-12-31: $2.5K2019-12-31: $1.3K2020-12-31: $35.9K2021-12-31: $66.0K$66.0K
2018-12-31 Cash & Equivalents (USD) 2021-12-31
Period endedCash & EquivalentsChange YoYSource filing
2021-12-31$66.0K+84.0%2022-03-31, Balance as of period end
2020-12-31$35.9Kn/m2022-03-31, Balance as of period end
2019-12-31$1.3K-47.7%2020-05-14, Balance as of period end
2018-12-31$2.5Kn/a2020-05-14, Balance as of period end